Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and Biogen Inc. said their experimental Alzheimer’s disease drug significantly slowed progression of the disease in Read more
Tag: progression
Enhertu significantly delayed breast cancer progression in trial, AstraZeneca says
AstraZeneca PLC said Monday that its Enhertu drug significantly delayed metastatic breast cancer progression in a Phase 3 trial, reinforcing the results of a prior trial. The Anglo-Swedish pharma giant Read more